These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5845896)

  • 1. Antimicrobial properties of a propylene glycol based topical therapeutic agent.
    Olitzky I
    J Pharm Sci; 1965 May; 54(5):787-8. PubMed ID: 5845896
    [No Abstract]   [Full Text] [Related]  

  • 2. SCALP DERMATOSES. TREATMENT WITH FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL.
    LUBOWE II
    Skin (Los Angeles); 1964 Sep; 3():267-9. PubMed ID: 14202034
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 4. [The suitability of propylene glycol (1,2-propanediol) as an active antimicrobial adjuvant in ointments].
    Bäurle G; Bieber S; Hornstein OP; Nürnberg E; Muckenschnabel R
    Z Hautkr; 1985 Aug; 60(15):1198-213. PubMed ID: 3931367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of 0.01 per cent solution of fluocinolone acetonide in propylene glycol].
    Aceves Ortega R
    Medicina (Mex); 1965 Apr; 45(962):171-6. PubMed ID: 5837268
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(5):337-43. PubMed ID: 4604483
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-infective action of a new steroid-base combination (fluclorolone acetonide in FAPG base) with conventional antimicrobial substances.
    Rhodes EL; Morison WL; Skinner GB; Borrett DW; Stoppard M
    Curr Med Res Opin; 1972; 1(2):87-92. PubMed ID: 4589022
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of vehicle composition. II. Prediction of optimal vehicle composition.
    Ostrenga J; Steinmetz C; Poulsen B; Yett S
    J Pharm Sci; 1971 Aug; 60(8):1180-3. PubMed ID: 5127091
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibacterial and antifungal properties of propylene glycol, hexylene glycol, and 1,3-butylene glycol in vitro.
    Kinnunen T; Koskela M
    Acta Derm Venereol; 1991; 71(2):148-50. PubMed ID: 1675525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of locally applied glucocorticoids.
    Raab WP
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):32-9. PubMed ID: 5004480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiments on the topical use of fluocinolone acetonide in propylene glycol].
    Vignali C
    Arcisp S Anna Ferrara; 1966; 19(4):535-40. PubMed ID: 5959876
    [No Abstract]   [Full Text] [Related]  

  • 14. [FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL. SOME RESULTS IN DERMATOLOGIC THERAPY].
    PELFINI C
    Minerva Dermatol; 1965 Jun; 40():245-7. PubMed ID: 14346246
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further observations with fluocinolone acetonide in local administration].
    Gatti JC; Cardama JE; Avila JJ; Carnevale Benino de Gar
    Prensa Med Argent; 1966 Sep; 53(35):1919-20. PubMed ID: 6011708
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of two fluorinated topical steroids in the treatment of common eczemas, on a once a day treatment schedule.
    Neumann L
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):74-6. PubMed ID: 5291637
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of seborrhea capitis with fluocinolone acetonide in propylene glycol: a clinical report.
    Yarborough JM; Burks JW
    J La State Med Soc; 1967 Jul; 119(7):290-1. PubMed ID: 4229894
    [No Abstract]   [Full Text] [Related]  

  • 18. A double blind evaluation of fluocinolone acetonide solution in the treatment of eborrheic dermatitis of the face.
    Snyder BL
    Pa Med; 1969 Jun; 72(6):68-9. PubMed ID: 4239005
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased scar formation with topical corticosteroid treatment.
    Berliner DL; Williams RJ; Taylor GN; Nabors CJ
    Surgery; 1967 Apr; 61(4):619-25. PubMed ID: 4225455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.